Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

How do the side-effects of the newer drugs compare with existing disease modifying drugs? Q10

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
389 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Feb 9, 2011

The MS Trust has asked Professor David Bates, Consultant Neurologist at University of Newcastle-upon-Tyne NHS Hospitals Foundation Trust to answer some of the most challenging questions people with MS ask about disease modifying drugs.

With newer, more potent MS drug therapies on the horizon, treatment decisions for both people with MS and their health professionals are about to become much more complex. It is more important than ever that people with MS have the information they need to make informed decisions in partnership with their health professionals. Health professionals need to communicate effectively with people with MS in order to quantify the risks and benefits of the various treatment options.

Need to know more? Why not ask Prof David Bates and Vicki Matthews questions from February 2011 to end of March 2011 by visiting the MS Trust Webcast pages -

http://www.mstrust.org.uk/information/webcast/questions/question_10_new_repla...

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more